Literature DB >> 22612574

Response inhibition deficits in unaffected first-degree relatives of patients with borderline personality disorder.

Anthony C Ruocco1, Lise Laporte2, Jennifer Russell2, Herta Guttman2, Joel Paris3.   

Abstract

OBJECTIVE: Impulsiveness is a heritable feature of borderline personality disorder (BPD) which aggregates in families affected with the illness. Whereas BPD patients show deficits on neuropsychological tests of response inhibition, it is unknown whether these deficits are also present in their first-degree biological relatives who are at an increased genetic risk for this illness. The purpose of the current study was to identify and characterize a subgroup of BPD patients with pronounced response inhibition deficits, and secondarily, to estimate the relative recurrence risk of these deficits among affected families.
METHOD: Thirty-nine pairs of female BPD probands and their unaffected first-degree biological sisters were recruited from hospital outpatient clinics. Participants completed the Conners' Continuous Performance Test (CPT) and the Barratt Impulsiveness Scale-11.
RESULTS: BPD relatives made a similar number of commission errors on the CPT compared to healthy controls with no personal or family history of psychiatric illness; however, cluster analysis revealed a subgroup of BPD relatives who displayed clinically elevated commission errors and atypically fast RTs to target stimuli, indicating a genuine response inhibition deficit. The estimated relative recurrence risk for response inhibition deficits for all sibling pairs on the CPT was moderate at λ = 4.55.
CONCLUSIONS: These findings suggest that response inhibition deficits are pronounced in some BPD relatives, may be heritable between siblings, are nonredundant with diagnostic status, and show promise as candidate neuropsychological endophenotypes for BPD.

Entities:  

Mesh:

Year:  2012        PMID: 22612574     DOI: 10.1037/a0028715

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  7 in total

1.  The contribution of familial internalizing and externalizing liability factors to borderline personality disorder.

Authors:  J I Hudson; M C Zanarini; K S Mitchell; L W Choi-Kain; J G Gunderson
Journal:  Psychol Med       Date:  2014-01-09       Impact factor: 7.723

Review 2.  Past, present, and future of genetic research in borderline personality disorder.

Authors:  Anahita Bassir Nia; Matthew C Eveleth; Jonathan M Gabbay; Yonis J Hassan; Bosi Zhang; M Mercedes Perez-Rodriguez
Journal:  Curr Opin Psychol       Date:  2017-09-12

3.  Subjective cognitive complaints and functional disability in patients with borderline personality disorder and their nonaffected first-degree relatives.

Authors:  Anthony C Ruocco; Jaeger Lam; Shelley F McMain
Journal:  Can J Psychiatry       Date:  2014-06       Impact factor: 4.356

4.  Relationships between reward sensitivity, risk-taking and family history of alcoholism during an interactive competitive fMRI task.

Authors:  Haley L Yarosh; Christopher J Hyatt; Shashwath A Meda; Rachel Jiantonio-Kelly; Marc N Potenza; Michal Assaf; Godfrey D Pearlson
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

Review 5.  Frontal dysfunctions of impulse control - a systematic review in borderline personality disorder and attention-deficit/hyperactivity disorder.

Authors:  Alexandra Sebastian; Patrick Jung; Annegret Krause-Utz; Klaus Lieb; Christian Schmahl; Oliver Tüscher
Journal:  Front Hum Neurosci       Date:  2014-09-03       Impact factor: 3.169

6.  Predicting Treatment Outcomes from Prefrontal Cortex Activation for Self-Harming Patients with Borderline Personality Disorder: A Preliminary Study.

Authors:  Anthony C Ruocco; Achala H Rodrigo; Shelley F McMain; Elizabeth Page-Gould; Hasan Ayaz; Paul S Links
Journal:  Front Hum Neurosci       Date:  2016-05-18       Impact factor: 3.169

7.  Theory of Mind in Borderline Personality Disorder: A Possible Endophenotypic Factor?

Authors:  Esther Ortega-Díaz; Jonatan García-Campos; Alejandro Moya-Martínez; Clara Ramírez-Cremades; José M Rico-Gomis; Carlos Cuesta-Moreno; Antonio Palazón-Bru; Gabriel Estan-Cerezo; José A Piqueras; Jesús Rodríguez-Marín
Journal:  Int J Environ Res Public Health       Date:  2021-03-19       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.